LC
AUPH icon

Lindbrook Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Lindbrook Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$9.57K Hold
1,190
– – ﹤0.01% 1670
2024
Q4 		$10.7K Hold
1,190
– – ﹤0.01% 1624
2024
Q3 		$8.72K Hold
1,190
– – ﹤0.01% 1744
2024
Q2 		$6.79K Buy
+1,190
New +$6.27K ﹤0.01% 1849
2024
Q1 		– Sell
-350
Closed -$3.15K – 2650
2023
Q4 		$3.15K Sell
350
-81
-19% -$667 ﹤0.01% 2094
2023
Q3 		$3.35K Buy
431
+169
+65% +$1.65K ﹤0.01% 1938
2023
Q2 		$2.54K Hold
262
– – ﹤0.01% 2058
2023
Q1 		$2.87K Sell
262
-5
-2% -$44 ﹤0.01% 2093
2022
Q4 		$1.15K Buy
+267
New +$1.55K ﹤0.01% 2432
2021
Q3 		– Sell
-4,000
Closed -$52K – 1848
2021
Q2 		$52K Buy
4,000
+1,000
+33% +$12.7K 0.01% 462
2021
Q1 		$39K Sell
3,000
-1,000
-25% -$14.5K 0.01% 523
2020
Q4 		$55K Buy
+4,000
New +$58.2K 0.01% 373
2020
Q3 		– Sell
-1,500
Closed -$24K – 1741
2020
Q2 		$24K Buy
+1,500
New +$24K 0.01% 548
2020
Q1 		– Sell
-3,500
Closed -$71K – 1679
2019
Q4 		$71K Buy
3,500
+2,000
+133% +$18.4K 0.02% 335
2019
Q3 		$8K Sell
1,500
-5,000
-77% -$30.3K ﹤0.01% 944
2019
Q2 		$42K Buy
6,500
+500
+8% +$3.19K 0.02% 465
2019
Q1 		$39K Buy
6,000
+4,000
+200% +$26.5K 0.02% 489
2018
Q4 		$13K Buy
+2,000
New +$11.5K 0.01% 743

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Lindbrook Capital's AUPH Position: Q1 2025 in Review

Lindbrook Capital held its Aurinia Pharmaceuticals (AUPH) position steady in Q1 2025 at 1,190 shares worth $9.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1670.

Lindbrook Capital first reported a position in AUPH in Q4 2018 and has held it in 18 quarters since. The position peaked at $71K in Q4 2019. 214 funds tracked by Wall St. Rank hold AUPH as of Q1 2025.

  • Lindbrook Capital held 1,190 shares of Aurinia Pharmaceuticals worth $9.57K as of Q1 2025.
  • Lindbrook Capital left its Aurinia Pharmaceuticals share count unchanged in Q1 2025.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1670 holding.
  • Lindbrook Capital first reported a position in Aurinia Pharmaceuticals in Q4 2018 and has held it in 18 quarters since.
  • Lindbrook Capital's Aurinia Pharmaceuticals position peaked at $71K in Q4 2019.
  • 214 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.